Publications, Pharmaceutical

Using digital therapeutics to improve inhaler use and patient outcomes

Poor disease control is a widely recognized issue for respiratory patients suffering from diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD); ineffective pressurized metered dose inhaler (pMDI) technique is a particularly common problem. This article considers how digital healthcare solutions can help. By measuring critical factors relating to technique, digital therapeutics can encourage patients to engage more effectively and confidently with pMDIs. Easy-to-use devices and apps enable both patients and health care practioners (HCPs) to screen, track and manage health. By improving patient compliance and behavior they can help HCPs to reduce long-term risk and maximize therapeutic efficacy. Key gains include a better clinical/patient dynamic, improved patient outcomes and lower emergency treatment costs.

For more information on ONdrugDelivery.

Download Publication
Author(s): Adam Shain
1 Jul 2021
Back To Top